EPEN-14. GENERATION OF A C11orf95-RELA FUSION TARGETING ANTIBODY AS A DIAGNOSTIC TOOL FOR SUPRATENTORIAL EPENDYMOMA

Lisa Ruff(Cancer Research UK Cambridge Center), Richard J. Gilbertson(St. Jude Children's Research Hospital), Mark Austin(John Innes Centre), Denice Y Chan(AstraZeneca (United Kingdom)), Lesley Jenkinson(AstraZeneca (United Kingdom)), Stuart W. Haynes(AstraZeneca (United Kingdom)), Sarah V. Holt(Pharma Nord (United Kingdom)), Maria Groves(AstraZeneca (United Kingdom))
Neuro-Oncology
December 1, 2020
10.1093/neuonc/noaa222.153
Cited by 0

Related Papers

Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Regulatory Role of <i>SGT1</i> in Early <i>R</i> Gene-Mediated Plant Defenses
|Science|2002|422
Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression
|Journal of Cell Science|2004|344
Arabidopsis <i>RAR1</i> Exerts Rate-Limiting Control of <i>R</i> Gene–Mediated Defenses against Multiple Pathogens
|The Plant Cell|2002|216